Skip to content
An Initiative of AVAC
Search
Back to Country Data

Country Overview:
Botswana

Global PrEP Tracker
Last Updated: 19 November 2024

Drug Registration Status

Approved
Not
Approved
Under
Review
Data not
available
Gilead's Truvada (TDF/xTC*) Registration
Approved 2016 2016
Generic versions of TDF/xTC* for prevention
Under Review
ViiV's Apretude (CAB for PrEP) Registration
Approved 2023 2023
IPM's Dapivirine Vaginal Ring Registration
Approved 2023 2023
Oral F/TAF (Descovy) Registration
Data Not Available
* TDF/xTC refers to tenofovir disoproxil fumarate (TDF) and either emtricitabine (FTC) or lamivudine (3TC)

Research, Demonstration and Implementation

Oral PrEP

N/A Completed Projects

Dapivirine Vaginal Ring

N/A Planned/Ongoing Projects

Injectable PrEP

1 Planned/Ongoing Projects

Policy Frameworks

Handbook of the Botswana 2016 Integrated HIV Clinical Care Guidelines

Est. Cumulative
Initiations:

Total PrEP: 47,422

Oral PrEP: 47,422

Dapivirine Vaginal Ring: N/A

Injectable PrEP: N/A

Where To Access PrEP in Botswana:

BOFWA

Legabibo

Nkaikela Youth Group

Featured Resources

Document

Botswana Strategic Direction Summary, 2023

PEPFAR Botswana’s vision for COP23 is “Partnering to Reach the Unmet and Sustain the Response”. Their goal is to maintain the progress made towards achieving the UNAIDS 95-95-95 targets and to close the remaining gaps across the People Living with HIV (PLHIV) cascade.
View All Resources